Visual analog scale questionnaire to assess quality of life specific to each symptom of the international prostate symptom score
Visual analog scale questionnaire to assess quality of life specific to each symptom of the international prostate symptom score
复制标题
DOI：
10.1016/j.juro.2006.03.031
复制
发表时间：
2006-08-01
影响因子：
6.6
通讯作者：
Miki, Tsuneharu
中科院分区：
文献类型：
--
作者：
Ushijima, So;Ukimura, Osamu;Miki, Tsuneharu
目的：采用一种新的视觉类比量表问卷对246例以下尿路症状为主诉的男性患者进行国际前列腺症状评分和视觉类比量表问卷调查，分别对国际前列腺症状评分的7个条目中的每一个条目进行患者生活质量的评估。结果：视觉类比量表最大值条目符合169例(69%)患者的主诉。相比之下，在104名患者(42%)中，主诉与国际前列腺症状评分最严重的项目不匹配(p=0.012)。多元回归分析表明，国际前列腺症状评分和视觉模拟评分对国际前列腺症状评分和生活质量评分的最佳预测因子是夜间尿量(p=0.0003)，其次是频率(p=0.0004)和不完全排空(p=0.0004)。经α-受体阻滞剂治疗后，主诉视觉模拟量表评分的改善与国际前列腺症状评分的改善相比，与国际前列腺症状评分的改善有更好的相关性。视觉模拟量表问卷对55名健康老年男性和44例下尿路症状患者的总体重测相关系数分别为0.772和0.742(p<；0.00001)。结论：国际前列腺症状评分的7个条目中的每一项都是一种新的生活质量视觉模拟量表，对识别患者主诉以及患者特定的生活质量有显著影响。我们的研究支持同时使用国际前列腺症状评分和视觉模拟量表问卷。
Purpose: We assessed patient quality of life specific to each of the 7 items on the International Prostate Symptom Score, as evaluated with a novel visual analog scale questionnaire.Materials and Methods: A total of 246 male patients with a chief complaint of lower urinary tract symptom were asked to complete the International Prostate Symptom Score and visual analog scale questionnaires to assess bother or satisfaction regarding patient quality of life specific to each of the 7 items on the International Prostate Symptom Score.Results: An item with the maximum visual analog scale measure matched the chief complaint in 169 patients (69%). In contrast, the chief complaint failed to match to an item with the most severe International Prostate Symptom Score in 104 patients (42%) (p = 0.012). Multiple regression analysis to define the best predictor of International Prostate Symptom Score quality of life score of the 14 items, including International Prostate Symptom Score and visual analog scale, revealed that the best predictor was the visual analog scale measure for nocturia (p = 0.0003), followed by visual analog scale measures for frequency (p = 0.0004) and incomplete emptying (p = 0.01). After a-blocker treatment improvement in the visual analog scale measure for the chief complaint correlated better with improvement in the International Prostate Symptom Score quality of life score than the change in International Prostate Symptom Score. The overall test-retest correlation for the visual analog scale questionnaire in 55 healthy elderly men and 44 patients with lower urinary tract symptoms was 0.772 and 0.742, respectively (p < 0.00001).Conclusions: The novel visual analog scale measure of quality of life specific to each of the 7 items on the International Prostate Symptom Score has a significant impact on identifying the patient chief complaint as well as on patient specific quality of life. Our study supports the concomitant use of the International Prostate Symptom Score and visual analog scale questionnaires.